Paola Tomassetti
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Correction to: Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.
Journal: Endocrine
Published: July 23, 2018
Everolimus in advanced, progressive, well-differentiated, non-functional neuroendocrine tumors: RADIANT-4 lung subgroup analysis.
Journal: Cancer science
Published: July 05, 2017
Benign Pancreatic Hyperenzymemia: Lights on a Clinical Challenge.
Journal: Pancreas
Published: December 16, 2016
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 14, 2016
Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.
Journal: Endocrine
Published: September 12, 2016
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.
Journal: Endocrine
Published: May 02, 2016
Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: October 08, 2015
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues.
Journal: Drug design, development and therapy
Published: September 15, 2015
Prognostic Value of 68Ga-DOTANOC PET/CT SUVmax in Patients with Neuroendocrine Tumors of the Pancreas.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 25, 2015
Real-world study of everolimus in advanced progressive neuroendocrine tumors.
Journal: The oncologist
Published: May 10, 2015
Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study.
Journal: Neuroendocrinology
Published: April 30, 2015
Last Updated: 09/26/2026